CSS LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $903K | Sell |
15,980
-5,200
| -25% | -$303K | 0.05% | 369 |
|
|
2025
Q4 | $1.26M | Sell |
21,180
-2,780
| -12% | -$151K | 0.07% | 259 |
|
|
2025
Q3 | $1.3M | Buy |
23,960
+12,650
| +112% | +$723K | 0.08% | 256 |
|
|
2025
Q2 | $622K | Buy |
+11,310
| New | +$666K | 0.04% | 483 |
|
|
2024
Q2 | – | Sell |
-3,600
| Closed | -$314K | – | 921 |
|
|
2024
Q1 | $314K | Hold |
3,600
| – | – | 0.03% | 561 |
|
|
2023
Q4 | $347K | Hold |
3,600
| – | – | 0.03% | 522 |
|
|
2023
Q3 | $319K | Buy |
+3,600
| New | +$320K | 0.03% | 498 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 956 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 839 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 805 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 546 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 559 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 545 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 535 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 614 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 628 |
|
|
2017
Q2 | – | Sell |
-3,863
| Closed | -$351K | – | 646 |
|
|
2017
Q1 | $339K | Hold |
3,863
| – | – | 0.02% | 400 |
|
|
2016
Q4 | $320K | Buy |
3,863
+650
| +20% | +$55.9K | 0.02% | 426 |
|
|
2016
Q3 | $297K | Buy |
+3,213
| New | +$303K | 0.02% | 482 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 703 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 675 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 688 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 763 |
|
Other funds holding BMRN
VCM
VPM
